Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Payables: 2020-2022

Historic Payables for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $1.6 million.

  • Terns Pharmaceuticals' Payables rose 58.79% to $3.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $13.2 million, marking a year-over-year increase of 92.07%. This contributed to the annual value of $1.6 million for FY2022, which is 22.62% down from last year.
  • Per Terns Pharmaceuticals' latest filing, its Payables stood at $1.6 million for FY2022, which was down 22.62% from $2.1 million recorded in FY2021.
  • Terns Pharmaceuticals' Payables' 5-year high stood at $2.1 million during FY2021, with a 5-year trough of $935,000 in FY2020.
  • Moreover, its 3-year median value for Payables was $1.6 million (2022), whereas its average is $1.6 million.
  • As far as peak fluctuations go, Terns Pharmaceuticals' Payables skyrocketed by 127.38% in 2021, and later dropped by 22.62% in 2022.
  • Yearly analysis of 3 years shows Terns Pharmaceuticals' Payables stood at $935,000 in 2020, then soared by 127.38% to $2.1 million in 2021, then decreased by 22.62% to $1.6 million in 2022.